Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$269.58 - $378.88 $219,977 - $309,166
-816 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$254.45 - $351.06 $293,635 - $405,123
-1,154 Reduced 58.58%
816 $257,000
Q4 2021

Feb 09, 2022

BUY
$272.01 - $353.03 $535,859 - $695,469
1,970 New
1,970 $690,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Blue Square Asset Management, LLC Portfolio

Follow Blue Square Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Square Asset Management, LLC with notifications on news.